Literature DB >> 9163020

Psychological and psychosexual implications of herpes simplex virus infections.

A Mindel1.   

Abstract

Genital herpes causes considerable psychological and psychosexual morbidity. The most common emotional responses are depression, anguish, anger, diminution in self-esteem and hostility towards the person believed to be the source of the infection. These emotional problems appear to be worse in women than in men. The psychological morbidity in patients with first episode genital herpes is statistically significantly greater than that occurring in non-herpes patients attending sexually transmitted disease clinics. It was previously believed that stressful life events could precipitate recurrences. However, recent studies suggest that ongoing recurrences cause the emotional stress rather than vice versa. There is some evidence that premorbid personality may effect recurrence rates, but an equally plausible explanation is that frequent recurrences adversely affect personality. Long-term aciclovir suppression significantly reduces the psychological morbidity associated with recurrent genital herpes, over at least the period of treatment. Cognitive coping strategies and social support from a partner appear to assist with adjustment. Improving a patient's problem-solving skills, and long-term aciclovir therapy should form an integral part of the long-term management of recurrent genital herpes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9163020

Source DB:  PubMed          Journal:  Scand J Infect Dis Suppl        ISSN: 0300-8878


  15 in total

Review 1.  Psychological symptoms associated with genital herpes virus infections: epidemiology and approaches to management.

Authors:  Adrian Mindel; Caron Marks
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

2.  Evaluation of confirmatory strategies for detection of type-specific antibodies against herpes simplex virus type 2.

Authors:  Bodo Rolf Eing; Lars Lippelt; Eva Ulla Lorentzen; Wali Hafezi; Wolfgang Schlumberger; Katja Steinhagen; Joachim Ewald Kühn
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

3.  First episodes of genital herpes in a Swedish STD population: a study of epidemiology and transmission by the use of herpes simplex virus (HSV) typing and specific serology.

Authors:  G B Löwhagen; P Tunbäck; K Andersson; T Bergström; G Johannisson
Journal:  Sex Transm Infect       Date:  2000-06       Impact factor: 3.519

Review 4.  [Herpes simplex virus infections].

Authors:  G Gross
Journal:  Hautarzt       Date:  2004-09       Impact factor: 0.751

5.  Role of type specific herpes simplex virus serology in the diagnosis and management of genital herpes.

Authors:  P E Munday; J Vuddamalay; M J Slomka; D W Brown
Journal:  Sex Transm Infect       Date:  1998-06       Impact factor: 3.519

6.  Attitudes and Willingness to Assume Risk of Experimental Therapy to Eradicate Genital Herpes Simplex Virus Infection.

Authors:  Linda Oseso; Amalia S Magaret; Keith R Jerome; Julie Fox; Anna Wald
Journal:  Sex Transm Dis       Date:  2016-09       Impact factor: 2.830

7.  Psychosocial impact of serological diagnosis of herpes simplex virus type 2: a qualitative assessment.

Authors:  J Melville; S Sniffen; R Crosby; L Salazar; W Whittington; D Dithmer-Schreck; R DiClemente; A Wald
Journal:  Sex Transm Infect       Date:  2003-08       Impact factor: 3.519

8.  Secreted portion of glycoprotein g of herpes simplex virus type 2 is a novel antigen for type-discriminating serology.

Authors:  Staffan Görander; Bo Svennerholm; Jan-Ake Liljeqvist
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

9.  Herpes simplex virus type 2 seropositivity and relationship status among U.S. adults age 20 to 49: a population-based analysis.

Authors:  Greta R Bauer; Nooshin Khobzi; Todd A Coleman
Journal:  BMC Infect Dis       Date:  2010-12-22       Impact factor: 3.090

10.  Suppressive valacyclovir therapy to reduce genital herpes transmission: good public health policy?

Authors:  Paul E Bonnar
Journal:  Mcgill J Med       Date:  2009-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.